ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "myocardial involvement and rheumatoid arthritis (RA)"

  • Abstract Number: 207 • 2018 ACR/ARHP Annual Meeting

    Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipids and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis

    Katherine P. Liao1, Jie Huang2, Gabrielle Cremone3, Ethan Lam3, Nicole Yang1, Martin Playford4, Christine K Iannaccone1, Jonathan Coblyn5, Elena Massarotti1, Michael E Weinblatt5, Nancy A. Shadick1, Nehal Mehta4 and Jorge Plutzky1, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Brigham and Women's Hospital, Boston, MA, 4NHLBI, Bethesda, MD, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Inflammation is an independent risk factor for cardiovascular (CV) risk in rheumatoid arthritis (RA). Paradoxically, potentially cardioprotective decreases in inflammation is associated with increased…
  • Abstract Number: 1070 • 2018 ACR/ARHP Annual Meeting

    Seroreactivity Against Recombinant Citrullinated Myosin Is Associated with Measures of Diastolic Dysfunction in Patients with Rheumatoid Arthritis

    Christian Geier1, Justyna Fert-Bober2, Jon T. Giles1, Cesare Russo1, Sabahat Bokhari3, Aylin Tugcu1, Jenny Van Eyk2 and Joan Bathon1, 1Columbia University, New York, NY, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Cardiology, Columbia University, New York, NY

    Background/Purpose: Diastolic dysfunction and heart failure with preserved EF are more prevalent in RA. We have previously shown increased staining for citrullinated substrates in necropsied…
  • Abstract Number: 1486 • 2016 ACR/ARHP Annual Meeting

    Associations Between Heart Rate Adjusted ST Segment and Heart Rate Variability in Patients with Rheumatoid Arthritis

    Ahmad Osailan1,2, Jet JJCS Veldhuijzen van Zanten2,3, Joan Duda1, Sally Fenton1,2, Peter Rouse4, Nikos Ntoumanis5, George D. Kitas1,2 and George Metsios2,6, 1School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, 2Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 3School of Sport, Exercise and Rehabilitation, University of Birmingham, Dudley, United Kingdom, 4Department for Health, University of Bath, Bath, United Kingdom, 5School of Psychology & Speech Pathology, Curtin University, Perth, Australia, 6Department of Physical Activity Exercise and Health, University of Wolverhampton, Walsall, United Kingdom

    Background/Purpose:  Patients with rheumatoid arthritis (RA) are at increased risk for myocardial infarction (MI), which is often silent. Heart rate adjusted ST segment (ST/HR index)…
  • Abstract Number: 1405 • 2014 ACR/ARHP Annual Meeting

    Five-Year Changes in Myocardial Structure and Function in Patients with Rheumatoid Arthritis

    John M. Davis III1, Grace Lin2, Jae Oh3, Cynthia S. Crowson4, Terry M. Therneau5, Eric L. Matteson1 and Sherine E. Gabriel6, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiology, Mayo Clinic, Rochester, MN, 3Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Rochester, MN, 5Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 6Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:   Patients with rheumatoid arthritis (RA) suffer an increased risk of heart failure not explained by traditional cardiovascular risk factors.  Previously, we have shown…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology